Author: Soma farag (United Kingdom)
Co-authors: Soma Farag, Maja Szymanska, Dalia Abdulhussein
Purpose
There is an increasing shift towards non-communicable diseases across all medical specialties. These have huge implications at multiple levels, from the patient level to the wider society level. Incorporation of telemedicine into everyday clinical practice is becoming increasingly popular. This is due, but not limited, to ease of use, ease of access and convenience. We sought to carry out a systematic review to look at which applications (apps) on portable devices are available for use by patients with non-communicable eye diseases (NCED) (refractive error, diabetic retinopathy (DR), age-related macular degeneration (AMD) and glaucoma).
Setting/Venue
Pubmed, EMBASE, Medline, PsychInfo databases were systematically searched using keywords and MeSH terms.
Methods
Pubmed, EMBASE, Medline, PsychInfo databases were systematically searched using keywords and MeSH terms. Eligible articles included peer-reviewed, original full text articles involving apps for use on portable devices aimed at patients with NCED. All articles identified were filtered by two independent reviewers. References were screened for additional records.
Results
The initial search yielded 100 studies, of which 40 passed initial screening. 14 studies met the inclusion criteria, and an additional 3 studies were identified through reference screening of included studies. 23% of the studies included investigated app use for glaucoma patients, 35% for AMD patients, 24% for DR patients and 18% for patients with normal vision to detect refractive error. All the applications were intended for diagnostic or monitoring purposes, with 47% monitoring visual fields, 41% testing visual acuity and 12% testing reading speed or monitoring fundus images. 52.9% of studies showed a statistical significance when compared to gold standard monitoring equivalents.
Conlusions
The use of portable device applications in patients with NCED has been shown to be effective. The use of these apps for patients is limited to either diagnostic or monitoring use. There is scope for apps which encompass other aspects of patient care that have been used in other specialties that may be applied to ophthalmic patients, including those with an educational aim which have a role in increasing compliance.
Financial Disclosure
None
Comments
-